Imaging Biometrics touts IB-Neuro recognition

By staff writers

June 22, 2020 -- Advanced visualization software firm Imaging Biometrics is touting the recognition of its IB Neuro software for use as a national standard for identifying high-grade brain tumors on MRI scans.

IB Neuro performs quantitative analysis of MRI dynamic susceptibility contrast (DSC) studies, a common perfusion MRI exam for evaluating brain tumors. Imaging Biometrics said that the software was included in the findings of a subcommittee on standardizing a DSC MRI protocol that was published in the journal Neuro-Oncology.

Imaging Biometrics believes that MRI-DSC imaging has been plagued by inconsistencies and suboptimal methods for acquiring and processing DSC-MRI scans. This results in mixed opinions regarding its usefulness. IB Neuro overcomes these limitations, according to the company.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking